Back
Cidara Therapeutics, Inc. Stock Price Chart
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
69
CDTX
Cidara Therapeutics, Inc.
Last Price:
$221.38
Seasonality Move:
-10.12%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
Cidara Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 221.37 | Buy |
| 20-day SMA: | 220.9 | Buy |
| 50-day SMA: | 197 | Buy |
| 200-day SMA: | 88.66 | Buy |
| 8-day EMA: | 221.28 | Buy |
| 20-day EMA: | 218.82 | Buy |
| 50-day EMA: | 194.9 | Buy |
| 200-day EMA: | 112.16 | Buy |
Cidara Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.67 | Buy |
| Relative Strength Index (14 RSI): | 84.21 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (220.23 - 221.27) | Buy |
| Bollinger Bands (100): | (74.57 - 207.23) | Buy |
Cidara Therapeutics, Inc. Technical Analysis
| Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 30 | 31 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics, Inc. Stock
Is Cidara Therapeutics, Inc. Stock a Buy?
-
Cidara Therapeutics, Inc. share price is 221.38 while CDTX 8-day simple moving average is 221.37, which is a Buy signal.
-
The stock price of CDTX is 221.38 while Cidara Therapeutics, Inc. 20-day SMA is 220.90, which makes it a Buy.
-
Cidara Therapeutics, Inc. 50-day simple moving average is 197.00 while CDTX share price is 221.38, making it a Buy technically.
-
CDTX stock price is 221.38 and Cidara Therapeutics, Inc. 200-day simple moving average is 88.66, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
69
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy or a Sell?
-
Cidara Therapeutics, Inc. stock is rated a BuyThe current Cidara Therapeutics, Inc. [CDTX] share price is $221.38. The Score for CDTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics, Inc. Stock Info
Market Cap:
7B
Price in USD:
221.38
Share Volume:
0
Cidara Therapeutics, Inc. 52-Week Range
52-Week High:
221.42
52-Week Low:
15.22
Buy
69
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Cidara Therapeutics, Inc. Share Price Forecast
-
What is the Cidara Therapeutics, Inc. stock price today?The Cidara Therapeutics, Inc. stock price is 221.38 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics, Inc. is not overvalued.
Is Cidara Therapeutics, Inc. Stock a Buy?
-
Cidara Therapeutics, Inc. share price is 221.38 while CDTX 8-day exponential moving average is 221.28, which is a Buy signal.
-
The stock price of CDTX is 221.38 while Cidara Therapeutics, Inc. 20-day EMA is 218.82, which makes it a Buy.
-
Cidara Therapeutics, Inc. 50-day exponential moving average is 194.90 while CDTX share price is 221.38, making it a Buy technically.
-
CDTX stock price is 221.38 and Cidara Therapeutics, Inc. 200-day simple moving average is 112.16, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics, Inc.
Is Cidara Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.59 per share.
Technical Analysis of Cidara Therapeutics, Inc.
Should I short Cidara Therapeutics, Inc. stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 5.67, suggesting Cidara Therapeutics, Inc. is a Buy
-
Cidara Therapeutics, Inc. Relative Strength Index (RSI) is 84.21, which suggest Cidara Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics, Inc. is (220.23 - 221.27), which suggest Cidara Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics, Inc. is (74.57 - 207.23), which suggest Cidara Therapeutics, Inc. is a Buy
* Cidara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.